3 results
Approved WMOPending
The objectives of this study are to evaluate: • the safety of VYC-25L injectable gel in subjects seeking to increase facial volume in the chin and jaw area • the performance of VYC-25L injectable gel in restoring and creating facial volume in the…
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOWill not start
This study will evaluate the safety, efficacy, and pharmacokinetics of UTTR1147A compared with placebo and compared with vedolizumab in patients with moderate to severe ulcerative colitis (UC).